These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 32026549)

  • 41. Effectiveness, cost effectiveness, acceptability and implementation barriers/enablers of chronic kidney disease management programs for Indigenous people in Australia, New Zealand and Canada: a systematic review of mixed evidence.
    Reilly R; Evans K; Gomersall J; Gorham G; Peters MD; Warren S; O'Shea R; Cass A; Brown A
    BMC Health Serv Res; 2016 Apr; 16():119. PubMed ID: 27048280
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cost-analysis of persistent hyperkalaemia in non-dialysis chronic kidney disease patients under nephrology care in Italy.
    Provenzano M; De Francesco M; Iannazzo S; Garofalo C; Andreucci M; Genualdo R; Borrelli S; Minutolo R; Conte G; De Nicola L
    Int J Clin Pract; 2020 May; 74(5):e13475. PubMed ID: 31909866
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The utility score of epilepsy with partial seizure measured by TTO, VAS, and EQ-5D in the general Korean population.
    Kang HJ; Kang E; Jo MW; Park EJ; Yoon S; Lee EK
    Epilepsy Res; 2014 Jul; 108(5):963-71. PubMed ID: 24679945
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Health-related quality of life in kidney transplant patients and non-renal replacement therapy patients with chronic kidney disease stages 3b-4.
    Stømer U; Bergrem H; Gøransson LG
    Ann Transplant; 2013 Nov; 18():635-42. PubMed ID: 24241237
    [TBL] [Abstract][Full Text] [Related]  

  • 45. How do people with chronic kidney disease value cancer-related quality of life?
    Wong G; Howard K; Chapman J; Pollock C; Chadban S; Salkeld G; Tong A; Williams N; Webster A; Craig JC
    Nephrology (Carlton); 2012 Jan; 17(1):32-41. PubMed ID: 22017753
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Health benefits and costs of screening for colorectal cancer in people on dialysis or who have received a kidney transplant.
    Wong G; Li MW; Howard K; Hua DK; Chapman JR; Bourke M; Turner R; Tong A; Craig JC
    Nephrol Dial Transplant; 2013 Apr; 28(4):917-26. PubMed ID: 23182812
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cost-effectiveness of home telemonitoring in chronic kidney disease patients at different stages by a pragmatic randomized controlled trial (eNephro): rationale and study design.
    Thilly N; Chanliau J; Frimat L; Combe C; Merville P; Chauveau P; Bataille P; Azar R; Laplaud D; Noël C; Kessler M
    BMC Nephrol; 2017 Apr; 18(1):126. PubMed ID: 28381266
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Real-world costs of autosomal dominant polycystic kidney disease in the Nordics.
    Eriksson D; Karlsson L; Eklund O; Dieperink H; Honkanen E; Melin J; Selvig K; Lundberg J
    BMC Health Serv Res; 2017 Aug; 17(1):560. PubMed ID: 28806944
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost of chronic kidney disease attributable to diabetes from the perspective of the Brazilian Unified Health System.
    Goncalves GMR; Silva END
    PLoS One; 2018; 13(10):e0203992. PubMed ID: 30273345
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Estimation of a valuation function for a diabetes mellitus-specific preference-based measure of health: the Diabetes Utility Index.
    Sundaram M; Smith MJ; Revicki DA; Miller LA; Madhavan S; Hobbs G
    Pharmacoeconomics; 2010; 28(3):201-16. PubMed ID: 20151725
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Standardised Outcomes in Nephrology-Children and Adolescents (SONG-Kids): a protocol for establishing a core outcome set for children with chronic kidney disease.
    Tong A; Samuel S; Zappitelli M; Dart A; Furth S; Eddy A; Groothoff J; Webb NJ; Yap HK; Bockenhauer D; Sinha A; Alexander SI; Goldstein SL; Gipson DS; Hanson CS; Evangelidis N; Crowe S; Harris T; Hemmelgarn BR; Manns B; Gill J; Tugwell P; Van Biesen W; Wheeler DC; Winkelmayer WC; Craig JC;
    Trials; 2016 Aug; 17():401. PubMed ID: 27519274
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of frailty on health-related quality of life in pre-dialysis patients with chronic kidney disease in Korea: a cross-sectional study.
    Lee SJ; Son H; Shin SK
    Health Qual Life Outcomes; 2015 May; 13():70. PubMed ID: 26021987
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cross-sectional survey in CKD patients across Europe describing the association between quality of life and anaemia.
    Eriksson D; Goldsmith D; Teitsson S; Jackson J; van Nooten F
    BMC Nephrol; 2016 Jul; 17(1):97. PubMed ID: 27460779
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sarcopenia and cardiovascular risk indices in patients with chronic kidney disease on conservative and replacement therapy.
    Lai S; Muscaritoli M; Andreozzi P; Sgreccia A; De Leo S; Mazzaferro S; Mitterhofer AP; Pasquali M; Protopapa P; Spagnoli A; Amabile MI; Molfino A
    Nutrition; 2019 Jun; 62():108-114. PubMed ID: 30875540
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The cost-effectiveness of using chronic kidney disease risk scores to screen for early-stage chronic kidney disease.
    Yarnoff BO; Hoerger TJ; Simpson SK; Leib A; Burrows NR; Shrestha SS; Pavkov ME;
    BMC Nephrol; 2017 Mar; 18(1):85. PubMed ID: 28288579
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chronic Kidney Disease in the Second-Generation Drug-Eluting Stent Era: Pooled Analysis of the Korean Multicenter Drug-Eluting Stent Registry.
    Lee JM; Kang J; Lee E; Hwang D; Rhee TM; Park J; Kim HL; Lee SE; Han JK; Yang HM; Park KW; Na SH; Kang HJ; Koo BK; Kim HS
    JACC Cardiovasc Interv; 2016 Oct; 9(20):2097-2109. PubMed ID: 27692820
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Incremental cost-utility of sevelamer relative to calcium carbonate for treatment of hyperphosphatemia among pre-dialysis chronic kidney disease patients.
    Nguyen HV; Bose S; Finkelstein E
    BMC Nephrol; 2016 Apr; 17(1):45. PubMed ID: 27121505
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association between health-related hope and adherence to prescribed treatment in CKD patients: multicenter cross-sectional study.
    Kurita N; Wakita T; Ishibashi Y; Fujimoto S; Yazawa M; Suzuki T; Koitabashi K; Yanagi M; Kawarazaki H; Green J; Fukuhara S; Shibagaki Y
    BMC Nephrol; 2020 Oct; 21(1):453. PubMed ID: 33129292
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neurocognitive and Educational Outcomes in Children and Adolescents with CKD: A Systematic Review and Meta-Analysis.
    Chen K; Didsbury M; van Zwieten A; Howell M; Kim S; Tong A; Howard K; Nassar N; Barton B; Lah S; Lorenzo J; Strippoli G; Palmer S; Teixeira-Pinto A; Mackie F; McTaggart S; Walker A; Kara T; Craig JC; Wong G
    Clin J Am Soc Nephrol; 2018 Mar; 13(3):387-397. PubMed ID: 29472306
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Abdominal aorta and pelvic artery calcifications on plain radiographs may predict mortality in chronic kidney disease, hemodialysis and renal transplantation.
    Disthabanchong S; Vipattawat K; Phakdeekitcharoen B; Kitiyakara C; Sumethkul V
    Int Urol Nephrol; 2018 Feb; 50(2):355-364. PubMed ID: 29236239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.